Sign in
Active, not recruitingNo phase

Esophageal String Test in Eosinophilic Esophagitis

Key facts

Who runs it
University of Colorado, Denver
Where
Aurora, Chicago, Indianapolis, and Peoria, United StatesSee the 6 sites
Trial code
Status
Active, not recruiting
People taking part
440 people, planned
Started
Jan 2009
Expected to end
Jan 2027
Type of study
Observational, 3 groups
Record updated
15 May 2026

Who can take part

Age
7 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients undergoing esophagogastroduodenoscopy (EGD) at Children's Hospital Colorado, or
  • Patients from a participating site in whom an inflammatory GI disease is suspected
  • Patients with symptoms of:; abdominal pain,; vomiting,; growth delay, or; malabsorption for which an etiology has not been determined
  • Patients with chronic eosinophilic esophagitis (EoE) in whom symptoms suggest ongoing inflammation

Who cannot take part

  • Patients suffering from bleeding diathesis, or any other comorbid condition which their doctor feels may put them at additional risk
  • Patients with a family history of connective tissue disease
  • Patients with a history of:; esophageal stricture, or; surgery such as fundoplication, or; allergy to gelatin, or; inability to swallow pills
  • Patients undergoing a therapeutic endoscopy (such as dilatation, sclerotherapy, variceal banding)

Where in United States

  • Children's Hospital ColoradoAurora, United States
  • University of Colorado HospitalAurora, United States
  • Lurie Children's HospitalChicago, United States
  • Northwestern UniversityChicago, United States
  • Indiana UniversityIndianapolis, United States
  • OSF St Francis Medical CenterPeoria, United States

About the trial

What the trial wants to find out

The overall goal of this study is to develop a novel minimally invasive device, the Esophageal String Test (EST) to monitor esophageal inflammation during treatment of the rare disease Eosinophilic Esophagitis (EoE) in a safe and efficacious manner.

Read full original descriptionShow less

This study is broken down into 2 specific aims:

Specific Aim 1: Identify the EoE Biomarker Panel (EBP) that will improve the sensitivity and specificity of the EST for documenting esophageal inflammation in a 1-hour time point.

Specific Aim 2: Validate the ability of the EST EBP to monitor therapeutic efficacy in a 1-hour sampling time.

Funding Source - FDA OOPD

The 3 groups in the trial

  • EoE active disease

    Inflammation as defined by \>15 eos / HPF

  • EoE remission

    No inflammation in EoE patients after treatment

  • normal control

    No inflammation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Phase 2 Study of Esophageal String Test in Diagnosing Eosinophilic Esophagitis
Record updated
15 May 2026